Work

Author Correction: NICE’s rejection of pembrolizumab for platinum-refractory urothelial carcinoma: is there a greater good?

Year: 2020

Type: erratum

Source: Nature Reviews Urology

DOI: 10.1038/s41585-020-0361-5

Authors: Shilpa Gupta, Ashish M. Kamat

Institutions: Cleveland Clinic, The University of Texas MD Anderson Cancer Center

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W3045590892

Cites:

Cited by:

Related to: 10